Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Chan

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
Nature|September 17, 2025
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancerAbbie S Ireland, Daniel A Xie, Sarah B Hawgood, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Actin Dysregulation Induces Neuroendocrine Plasticity and Immune Evasion: A Vulnerability of Small Cell Lung CancerYoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Nature Communications|December 6, 2025
Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancerYoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Cancer Research|November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line ChemotherapyAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Science (New York, N.Y.)|August 18, 2022
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signalingJoseph M Chan, Samir Zaidi, Jillian R Love, et al.
Cell Reports|April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancerAlessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Cancer Cell|February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Journal of Hematology & Oncology|October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2022
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLCEvelyn M Nguyen, Hirokazu Taniguchi, Joseph M Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i>-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.
Nature|September 17, 2025
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancerAbbie S Ireland, Daniel A Xie, Sarah B Hawgood, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Actin Dysregulation Induces Neuroendocrine Plasticity and Immune Evasion: A Vulnerability of Small Cell Lung CancerYoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Nature Communications|December 6, 2025
Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancerYoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Cancer Research|November 24, 2021
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line ChemotherapyAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yuan Hao, et al.
Science (New York, N.Y.)|August 18, 2022
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signalingJoseph M Chan, Samir Zaidi, Jillian R Love, et al.
Cell Reports|April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancerAlessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Cancer Cell|February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Journal of Hematology & Oncology|October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Pageof 3